Lin, EH, von Korff, M.
Mental disorders among persons with diabetes – results from the World Mental Health Surveys. J Psychosom Res
2008; 65: 571–80.
Schram, MT, Baan, CA, Pouwer, F.
Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) research consortium. Curr Diabetes Rev
2009; 5: 112–9.
Snoek, FJ, Bremmer, MA, Hermanns, N.
Depression and diabetes 1: constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol
2015; 3: 450–60.
Smit, F, Cuijpers, P, Oostenbrink, J, Batelaan, N, de Graaf, R, Beekman, A.
Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ
2006; 9: 193–200.
Simon, GE, Katon, WJ, Lin, EHB, Ludman, E, von Korff, M, Ciechanowski, P, et al.
Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry
2005; 27: 344–51.
Lehnert, T, Konnopka, A, Riedel-Heller, S, König, HH.
Diabetes mellitus and comorbid depression: economic findings from a systematic literature review. Psychiatr Prax
2011; 38: 369–75.
Von Korff, M, Katon, W, Lin, EHB, Simon, G, Ciechanowski, P, Ludman, E, et al.
Work disability among individuals with diabetes. Diabetes Care
2005; 28: 1326–32.
Baumeister, H, Hutter, N, Bengel, J.
Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Syst Rev
2012; 12: CD008381.
Kok, JL, Williams, A, Zhao, L.
Psychosocial interventions for people with diabetes and co-morbid depression. A systematic review. Int J Nurs Stud
2015; 52: 1625–39.
Jeeva, F, Dickens, C, Coventry, P, Bundy, C, Davies, L.
Is treatment of depression cost-effective in people with diabetes? A systematic review of the economic evidence. Int J Technol Assess Health Care
2013; 29: 384–91.
Richards, D, Richardson, T.
Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev
2012; 32: 329–42.
Nobis, S, Lehr, D, Ebert, DD, Baumeister, H, Snoek, F, Riper, H, et al.
Efficacy of a web-based intervention with mobile phone support in treating depressive symptoms in adults with type 1 and type 2 diabetes: a randomized controlled trial. Diabetes Care
2015; 38: 776–83.
Ebert, D, Nobis, S, Lehr, D, Baumeister, H, Riper, H, Auerbach, RP, Snoek, F, Berking, M.
The 6-month effectiveness of Internet-based guided self-help for depression in adults with type 1 and 2 diabetes mellitus. Diabetic Med
2016; 34: 90–107.
van Bastelaar, KMP, Pouwer, F, Cuijpers, P, Riper, H, Snoek, FJ.
Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care
2011; 34: 320–5.
Andersson, G, Titov, N.
Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry
2014; 13: 4–11.
Hollinghurst, S, Peters, TJ, Kaur, S, Wiles, N, Lewis, G, Kessler, D.
Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial. Br J Psychiatry
2010; 197: 297–304.
Warmerdam, L, Smit, F, van Straten, A, Riper, H, Cuijpers, P.
Cost-utility and cost-effectiveness of internet-based treatment for adults with depressive symptoms: randomized trial. J Med Internet Res
2010; 12: e53.
Gerhards, SAH, de Graaf, LE, Jacobs, LE, Severens, JL, Huibers, MJH, Arntz, A, et al.
Economic evaluation of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial. Br J Psychiatry
2010; 196: 310–8.
McCrone, P, Knapp, M, Proudfoot, J, Ryden, C, Cavanagh, K, Shapiro, DA, et al.
Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry
2004; 185: 55–62.
Geraedts, AS, van Dongen, JM, Kleiboer, AM, Wiezer, NM, van Mechelen, W, Cuijpers, P, et al.
Economic evaluation of a web-based guided self-help intervention for employees with depressive symptoms: results of a randomized controlled trial. J Occup Environ Med
2015; 57: 666–75.
Nobis, S, Lehr, D, Ebert, DD, Berking, M, Heber, E, Baumeister, H, et al.
Efficacy and cost-effectiveness of a web-based intervention with mobile phone support to treat depressive symptoms in adults with diabetes mellitus type 1 and type 2: design of a randomised controlled trial. BMC Psychiatry
2013; 13: 306.
Hautzinger, M, Bailer, M, Hofmeister, D, Keller, F.
Allgemeine Depressionsskala. [General Depression Scale.]
2nd edn. Hogrefe Publishing, 2012.
The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas
1977; 1: 385–401.
Cuijpers, P, van Straten, A, Warmerdam, L.
Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev
2007; 27: 318–26.
Cuijpers, P, van Straten, A, Warmerdam, L.
Problem solving therapies for depression: a meta-analysis. Eur Psychiatry
2007; 22: 9–15.
26BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW. S3 Guideline unipolar depression, 2015 (http://www.leitlinien.de/mdb/downloads/nvl/depression/archiv/depression-2aufl-vers1-lang.pdf).
Jacobson, NS, Truax, P.
Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol
1991; 59: 12–9.
Drummond, MF, Sculpher, MJ, Torrance, GW, O'Brien, BJ, Stoddart, GL.
Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford University Press, 2005.
EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy
1990; 16: 199–208.
Modeling valuations for EuroQol health states. Med Care
1997; 35: 1095–108.
Hakkaart-van Roijen, L.
Manual Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness (in Dutch). Institute for Medical Technology Assessment, 2002.
Krauth, C, Hessel, F, Hansmeier, T, Wasem, J, Seitz, R, Schweikert, B.
Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation - ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG). [Empirical Standard Costs for Health Economic Evaluation in Germany - a Proposal by the Working Group Methods in Health Economic Evaluation.]
2005; 67: 736–46.
Bock, JO, Brettschneider, C, Seidl, H, Bowles, D, Holle, R, Greiner, W, et al.
Ermittlung standardisierter Bewertungssätze aus gesellschaftlicher Perspektive für die gesundheitsökonomische Evaluation. [Calculation of Standardised Unit Costs from a Societal Perspective for Health Economic Evaluation.]
2014; 77: 53–61.
Husereau, D, Drummond, M, Petrou, S, Stavros, P, Carswell, C, Moher, D, et al.
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health
2013; 16: 231–50.
van Hout, BA, Al, MJ, Gordon, GS, Rutten, FFH.
Costs, effects and C/E-ratios alongside a clinical trial. Health Econ
1994; 3: 309–19.
Schafer, JL, Graham, JW.
Missing data: our view of the state of the art. Psychol Methods
2002; 7: 147–77.
Matthews, JN, Altman, DG, Campbell, MJ, Royston, P.
Analysis of serial measurements in medical research. BMJ
1990; 300: 230–5.
Barrett, B, Byford, S.
Acceptable mental health care? A new decision-making tool for cost-effectiveness analysis. Ment Health Res Rev
2001; 9: 39–41.
Hirth, RA, Chernew, ME, Miller, E, Fendrick, AM, Weissert, WG.
Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making
2000; 20: 332–42.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Dsm-IV (4th ed). American Psychiatric Press, 1994.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW.
User Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders. American Psychiatric Association, 1996.
Mihalopoulos, C, Chen, G, Iezzi, A, Khan, MA, Richardson, J.
Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures. Br J Psychiatry
2014; 205: 390–7.
Turner, N, Campbell, J, Peters, TJ, Wiles, N, Hollinghurst, S.
A comparison of four different approaches to measuring health utility in depressed patients. Health Qual Life Outcomes
2013; 11: 81.
Faria, R, Gomes, M, Epstein, D, White, IR.
A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics
2014; 32: 1157–70.
Egede, LE, Ellis, C.
Diabetes and depression: global perspectives. Diabetes Res Clin Pract
2010; 87: 302–12.